---
schema_version: "secwatch.filing_event.v1"
accession: "0001731122-26-001144"
form_type: "8-K"
ticker: "SBEV"
cik: "0001553788"
company_name: "SPLASH BEVERAGE GROUP, INC."
filed_at: "2026-08-25T12:31:20+00:00"
generated_at: "2026-08-25T12:35:10.188284+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Endovia achieves first FDA regulatory milestone for CannEpil veterinary program

## Summary
- FDA Center for Veterinary Medicine established INAD File No. 14145 for CannEpil development program.
- First milestone under collaboration with Lupvindol Biosciences Ltd.; formally initiates FDA regulatory process.
- Initial target: management of cancer-related pain in companion animals, starting with canine oncology.
- Company intends to pursue FDA Minor Use/Minor Species (MUMS) designation and Conditional Approval pathway.

## SEC filing metadata
- accession: 0001731122-26-001144
- form_type: 8-K
- ticker: SBEV
- cik: 0001553788
- company_name: SPLASH BEVERAGE GROUP, INC.
- filed_at: 2026-08-25T12:31:20+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553788/000173112226001144/0001731122-26-001144-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553788/000173112226001144/e7891_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001731122-26-001144
- JSON: https://secwatch.observer/filing/0001731122-26-001144.json
- Plain text: https://secwatch.observer/filing/0001731122-26-001144.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.